Updated Biography Oct. 2017: Justin Chan joined the Berkman Center as a Fellow in August 2001, where he focused on the evolution of rules in the digital economy: how the economics of new technology compels changes in the law, and specifically how formal and informal methods of rule dissemination, such as through trade organizations, impact innovation and competitiveness in Asian economies.
Justin is currently a Managing Director and General Counsel for BlackRock Solutions, the $800m+ financial technology division of BlackRock, the world's largest asset manager with approximately $6 trillion of assets under management. He is responsible for the global legal team that supports the firm's Aladdin, Advisory, Digital Wealth and Cachematrix businesses, data and technology service relationships and the development of BlackRock's signal-driven, data science and artificial intelligence infrastructure.
Before joining BlackRock, Justin represented the investment interests of D. E. Shaw & Co, an investment and technology firm based in New York, focusing on D. E. Shaw's renewable energy investments in onshore and offshore wind as well as clean coal. While at DESCO, he was also a board member of Snikiddy, Inc. and general counsel of Schrodinger, a computational drug discovery enterprise funded by David Shaw and Bill Gates.
Prior to Schrodinger, Justin was a corporate law associate at Debevoise & Plimpton, LLP.
Before joining the Berkman Center, Justin clerked for Chief Justice Yong at the Singapore Supreme Court and established the Information Technology Law Program at the Singapore Academy of Law. He graduated from Cambridge University with First Class Honors, receiving the George Long Prize for Roman Law. He also holds a Diploma in Singapore Law from the National University of Singapore, where he received the Rajah & Tann Prize for Insolvency Law. He completed his LL.M. at Harvard Law School with a full scholarship, receiving the highest class result for Charlie Nesson's The Exploding Internet for his analysis of anticompetition claims against Microsoft, and the ASPL-Knoll Legal Research Award for his work in pharmaceutical law. He has been a visiting lecturer at both the National University of Singapore and the University of Washington.